corporate_fare

Rein Therapeutics Inc.

Address
12407 North Mopac Expressway Suite 250 # 390

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
8
research centres
public
2
countries
person_search
6
investigators

Specializations

Interstitial Lung Disease

Rein Therapeutics Inc. is focused on idiopathic pulmonary fibrosis, with clinical research centered on the management of progressive lung scarring and its impact on respiratory function.

  • Idiopathic pulmonary fibrosis
  • Fibrotic lung disease
  • Chronic respiratory impairment

The sponsor’s current trial activity reflects interest in treatment options for patients living with established pulmonary fibrosis and related respiratory decline.

Antifibrotic Therapy

Its clinical development program includes patients who may already be receiving standard-of-care antifibrotic therapy, indicating attention to treatment settings where disease-modifying lung therapies are part of routine care.

  • Antifibrotic treatment
  • Standard-of-care therapy
  • Disease progression control

Research activity in this domain is directed toward therapeutic options intended for use alongside existing pulmonary fibrosis management.

Inhaled Pulmonary Delivery

The sponsor is exploring inhaled therapy for lung disease, with interest in treatments designed to act directly within the respiratory tract.

  • Inhaled administration
  • Local pulmonary targeting
  • Respiratory drug delivery

This area highlights a therapeutic focus on delivery approaches relevant to chronic fibrotic conditions affecting the lungs.

Clinical Safety and Tolerability

Current research activity places emphasis on safety, tolerability, and treatment experience in people with idiopathic pulmonary fibrosis.

  • Safety evaluation
  • Tolerability assessment
  • Patient treatment experience

These interests align with clinical development in a population affected by a serious, progressive lung disorder.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 1 total (100% not shared with other sponsors)

This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 8 sites collaborated multiple times

This sponsor has worked with 8 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Cardiovascular Diseases1 trial
    359 other sponsors

Partnered Research Centres

8 centres
location_city
assignment2
Agaplesion Evangelisches Krankenhaus Mittelhessen gGmbH
Address
Paul-Zipp-Strasse 171, 35398 Giessen
Learn morearrow_forward
location_city
assignment35
National Institute Of Tuberculosis And Lung Diseases
Address
Ul. Plocka 26, 01-138 Warsaw
Learn morearrow_forward
location_city
assignment2
PULMAG s. c.
Address
ul. Konstytucji 68, 41-208 Sosnowiec
Learn morearrow_forward
location_city
assignment48
Ruhrlandklinik Westdeutsches Lungenzentrum Am Universitaetsklinikum Essen gGmbH
Address
Tueschener Weg 40, Heidhausen, 45239 Essen
Learn morearrow_forward
location_city
assignment133
Thoraxklinik Heidelberg gGmbH
Address
Roentgenstrasse 1, Rohrbach, 69126 Heidelberg
Learn morearrow_forward
location_city
assignment79
Twoja Przychodnia Nowosolskie Centrum Medyczne Sp. z o.o.
Address
Ul. Glowackiego 8d/2, 67-100 Nowa Sol
Learn morearrow_forward
Page 1 of 2

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Rein Therapeutics Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.